Saturday, 8 June
10.15 - 11.15 |
|
hematology-in-focus sessions |
Leonardo |
SECONDARY LEUKEMIAS
Chair: S. Tura (Ospedale S. Orsola, Bologna, Italy)
IDENTIFICATION AND STUDY OF GENETIC LESIONS IN RETROVIRALLY
INDUCED MYELOID LEUKEMIAS IN MOUSE, USING IN VIVO FUNCTIONAL
SCREENS
R. Delwel (Erasmus University Rotterdam, Rotterdam, The Netherlands)
EPIDEMIOLOGY AND CLINICAL ISSUES
D. Ben-Yehuda (Hadassah Medical Centre, Jerusalem, Israel) |
Caravaggio |
SIGNAL TRANSDUCTION IN HEMATOLOGICAL
MALIGNANCIES
Chair: I. Touw (Erasmus University Rotterdam, Rotterdam,
The Netherlands)
MAPPIT, A CYTOKINE RECEPTOR-BASED INTERACTION TRAP
FOR THE IDENTIFICATION OF NOVEL SIGNALING MECHANISMS
IN HEMATOPOIETIC DISEASE
J. Tavernier (Flanders Interuniversity Institute for Biotechnology,
Ghent, Belgium)
THE ROLE OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA
H. Serve (University Clinic, Münster, Germany) |
Botticelli |
MOLECULAR DIAGNOSIS I
Chair: D. Hoelzer (Johann-Wolfgang-Goethe-Universität, Frankfurt,
Germany)
ACUTE MYELOID LEUKEMIA
F. Lo Coco (Cellular Biotechnology and Hematology, Rome, Italy)
ACUTE LYMPHOCYTIC LEUKEMIA
E. Macintyre (Hospital Necker Enfants Malades, Paris, France) |
Raffaello |
IN UTERO STEM CELL TRANSPLANTATION
Chair: G. De Rossi (Bambino Gesù Hospital, Rome, Italy)
A FILIATION OF HEMATOPOIETIC CELLS FROM VASCULAR ENDOTHELIUM
B. Péault (Hospital Paul Brousse, Villejuif, France)
PRELIMINARY CLINICAL INDICATIONS
A. Ugazio (Bambino Gesù Hospital, Rome, Italy) |
Tiziano |
DO WE NEED A PET ANALYSIS IN EVERY LYMPHOMA PATIENT?
Chair: E. Montserrat (Hospital Clinic, Barcelona, Spain)
DO WE NEED A PET ANALYSIS IN EVERY LYMPHOMA PATIENT?
G. Jérusalem (CHU Liège, Liège, Belgium) |
Tintoretto |
MANTLE CELL LYMPHOMA
Chair: A. Hagenbeek (University Hospital Utrecht, Utrecht,
The Netherlands)
ARE ALL T(11,14) LEUKEMIA/LYMPHOMAS VARIANTS OF MANTLE CELL
LYMPHOMA?
D.G. Oscier (Royal Bournemouth Hospital, Bournemouth, United Kingdom)
PATHOLOGY OF MANTLE CELL LYMPHOMA
H.K. Müller-Hermelink (University of Wurzburg, Wurzburg, Germany) |
Giotto |
PREVENTION AND DETECTION OF BLOOD DOPING
Chair: M. Cazzola (IRCCS Policlinico San Matteo, Pavia, Italy)
SCIENCE AND INDUSTRY AGAINST BLOOD DOPING
M. Ashenden (Science and Industry Against Blood-doping (SIAB) project,
Gumeracha, Australia)
THE SAFE PARADIGM: DETERRENCE AND DETECTION OF BLOOD DOPING METHODS
J. Stray-Gundersen (Norwegian University of Sport and Physical
Education, Oslo, Norway) |
Sunday, 9 June
10.15 - 11.15 |
hematology-in-focus sessions |
Caravaggio |
LATENCY MECHANISMS OF HERPES VIRUSES
Chair: G. Torelli (University of Modena, Modena, Italy)
EPSTEIN-BARR VIRUS
M. Rowe (University of Wales College of Medicine, Cardiff,
United Kingdom)
CYTOMEGALOVIRUS
V.C. Emery (Royal Free and University College Medical School, London,
United Kingdom) |
Botticelli |
TUMOR SPECIFIC CELL THERAPY
Chair: S. Slavin (Hadassah University, Jerusalem, Israel)
IN VITRO IDENTIFICATION OF TUMOR SPECIFIC T CELLS FOR IMMUNOTHERAPY
J.H.F. Falkenburg (Leiden University Medical Centre, Leiden,
The Netherlands)
PRELIMINARY RESULTS IN CHRONIC MYELOID LEUKEMIA
J. Goldman (Imperial College School of Medicine at Hammersmith
Hospital, London, United Kingdom) |
Raffaello |
BIOLOGY OF STEM CELL MOBILISATION AND MIGRATION
Chair: C. Carlo-Stella (Istituto Tumori, Milan, Italy)
MECHANISM OF HUMAN STEM CELL MIGRATION AND REPOPULATION OF NOD/SCID MICE
T. Lapidot (The Weizmann Institute of Science, Rehovot, Israel)
CHARACTERIZATION OF MOBILIZED STEM CELLS: A COMPARATIVE ANALYSIS WITH BONE MARROW REVEALS A PREDOMINANCE OF SHORT TERM REPOPULATING CELLS
H. Glimm (Albert Ludwigs University, Freiburg, Germany) |
Tiziano |
MOLECULAR DIAGNOSIS II
Chair: B.D. Young (ICRF Medical Oncology Unit, London, United Kingdom)
LYMPHOMA
B. Schlegelberger (Medical School of Hannover, Hannover, Germany)
CHROMOSOMAL DEFECTS IN MYELOMA
H. Avet-Loiseau (Institute of Biology, Nantes, France) |
Tintoretto |
THALIDOMIDE IN HEMATOLOGICAL MALIGNANCIES
Chair: A. Ganser (Hannover Medical School, Hannover, Germany)
THALIDOMIDE IN HEMATOLOGICAL MALIGNANCIES
J.L. Harousseau (University Hospital Nantes, Nantes, France) |
Giotto |
HEMOVIGILANCE IN EUROPE
Chair: P. Rebulla (IRCCS Ospedale Maggiore, Milan, Italy)
THE FRENCH SYSTEM
D. Rebibo (Etablissement Français du Sang, Paris, France)
THE SYSTEM IN THE UNITED KINGDOM
E. Love (Manchester Blood Centre, Manchester, United Kingdom)
ONE EUROPE, ONE SYSTEM?
M. Marconi (IRCCS Hospital Maggiore, Milan, Italy) |
 |